Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

ViePax XL 150 mg Prolonged-Release Tablets

Active Ingredient:
venlafaxine hydrochloride
Company:  
Dexcel Pharma Ltd See contact details
ATC code: 
N06AX16
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Product Information HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Venlafaxine hydrochloride – ViePax XL 150 mg prolonged-release tablets - June 2021

ViePax XL 150 mg prolonged-release tablets (PL 14017/0119) will be replaced by the similar product ViePax XL Dexcel 150 mg prolonged-release tablets (14017/0283).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Dexcel Pharma Ltd
Company image
Address
7, Sopwith Way, Drayton Fields, Daventry, Northamptonshire, NN11 8PB, UK
Telephone
+44 (0)1327 312 266
Fax
+44 (0)1327 312 262
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0) 1748 828 784
WWW
http://www.dexcelpharma.com
Out of Hours Telephone
+44 (0) 1748 828 784
E-mail
[email protected]